Click image to enlarge
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Phosphoproteins
,
Intracellular Signaling
|
|
Analyte(s)
|
|
S6RP
|
|
Species
|
|
Human, Non-human primate, Mouse, Rat
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
Plate Type
|
|
96-well
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 0.1 mL
|
2-8 °C
|
1 each (0.1 mL)
|
|
Phosphatase Inhibitor II 0.1 mL
|
2-8 °C
|
1 each (1 each)
|
|
Protease Inhibitor Solution 0.1 mL
|
2-8 °C
|
1 each (1 each)
|
|
SULFO-TAG Anti-Total S6RP Antibody
|
2-8 °C
|
1 vial (75 μL)
|
|
Total S6RP Plate
|
2-8 °C
|
1 each (1 each)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (15 g)
|
|
|
≤-10 °C
|
1 vial (0.2 mL)
|
|
MSD Blocker D-R, 0.05 mL
|
≤-10 °C
|
1 vial (1 vial)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
Phosphatase Inhibitor II 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
Protease Inhibitor Solution 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
SULFO-TAG Anti-Total S6RP Antibody
|
2-8 °C
|
1 vial (375 μL)
|
|
Total S6RP Plate
|
2-8 °C
|
5 each (1 each)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (15 g)
|
|
|
≤-10 °C
|
1 vial (0.2 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 2.0mL
|
2-8 °C
|
1 each (1 each)
|
|
Phosphatase Inhibitor II 2.0mL
|
2-8 °C
|
1 each (1 each)
|
|
Protease Inhibitor Solution 2.0mL
|
2-8 °C
|
1 each (1 each)
|
|
SULFO-TAG Anti-Total S6RP Antibody
|
2-8 °C
|
4 vial (375 μL)
|
|
Total S6RP Plate
|
2-8 °C
|
20 each (1 each)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
2-8 °C
|
1 bottle (1000 mL)
|
|
|
RT
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (15 g)
|
|
|
≤-10 °C
|
4 vial (0.2 mL)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
|
|
|
|
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
|
|
|
|
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response.
|
|
|
|
Weekly nab-rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial.
|
|
|
|
mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters